Cargando…
Activity-Based Protein Profiling Reveals Potential Dasatinib Targets in Gastric Cancer
Dasatinib is a multi-target kinase inhibitor, whose targets include BCR-ABL, SRC family kinases, and various cancer kinases. The elevated SRC activity in gastric cancer (GC) has prompted the need for the therapeutic application of dasatinib in GC. We observed that the efficacy of dasatinib varied wi...
Autores principales: | Choi, Kyoung-Min, Cho, Eunji, Bang, Geul, Lee, Seong-Jae, Kim, Boram, Kim, Ji-Hee, Park, Seo-Gyu, Han, Eun Hee, Chung, Young-Ho, Kim, Jin Young, Kim, Eunjung, Kim, Jae-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729964/ https://www.ncbi.nlm.nih.gov/pubmed/33291786 http://dx.doi.org/10.3390/ijms21239276 |
Ejemplares similares
-
Identification of Nucleolin as a Novel AEG-1-Interacting Protein in Breast Cancer via Interactome Profiling
por: Lee, Seong-Jae, et al.
Publicado: (2021) -
Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia
por: Hong, Ji Hyung, et al.
Publicado: (2015) -
Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death
por: Heo, Sook-Kyoung, et al.
Publicado: (2017) -
Multi-omics data of gastric cancer cell lines
por: Seo, Eun-Hye, et al.
Publicado: (2023) -
Author Correction: Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death
por: Heo, Sook-Kyoung, et al.
Publicado: (2021)